Alkem Laboratories Ltd incorporates Saudi JV subsidiary with a 51% stake in SAR 7.5 million capital
- Alkem subscribed to 38,250 shares for SAR 3.825 million.
- The JV will manufacture, import, market and distribute pharmaceutical and nutraceutical products in Saudi Arabia.
- The investment is not a related-party transaction; no regulatory approvals are required.